"The Infinite" lands in Houston for the first U.S. show. Image courtesy of Infinity Productions

From the earliest days of our circling the planet in a tiny NASA capsule — to Elon Musk's SpaceX current commercial journeys — Houston and space travel will be forever and inexorably linked.

Fitting, then, that an unprecedented new immersive experience centered on the International Space Station (ISS) is making its U.S. debut here in Space City. "The Infinite"— a multi-sensory, interactive virtual reality experience — will zoom into Sawyer Yards on December 20 for a special, and limited, run, organizers announced.

This sprawling, 12,500-square-foot exhibition shuttles viewers into a never-before-seen perspective of life on the ISS, bringing an almost-too-real feeling of being in outer space.

Tickets are on sale now for a soft open preview period beginning on December 20; admission is $29. Tickets then jump to $36 for the full-scale limited engagement beginning on January 13, 2022.

Boasting footage shot over a period of nearly three years that created some 200 hours of high-end virtual reality scenes, the four-part immersive series documents the life of eight international astronauts inside — and outside — the International Space Station. (The outside experience promises to be an especially wild ride.) The show comes to Houston off a wildly popular Canadian run in Montreal.

Specific to this Houston launch, the show boasts new footage from the first-ever cinematic spacewalk captured in 3D — 360-degree virtual reality shot outside the International Space Station on September 12, 2021 — while offering visitors a self-directed experience aboard the ISS itself, according to a press release.

Throughout the 60-minute journey, per press materials, viewers will engage with physical objects, virtual reality, multimedia art, soundscapes, light design, and even the subtle scents of a forest, meant to evoke memories of stargazing while lying on the grass.

"The Infinite" is the brainchild of Montreal-based Infinity Experiences, a joint venture of PHI Studio and Felix & Paul Studios, and is an extension of the recent Primetime Emmy Award-winning immersive series, "Space Explorers: The ISS Experience," the largest production ever filmed in space, produced by Felix & Paul Studios in association with Time Studios.

That this show will run next year is also especially timely for Houston's space saga. Next year marks the 60th anniversary of President John F. Kennedy's famous moon-shot speech given at Rice University on September 12, 1962. That speech, with its now-legendary "we choose to go to the moon" line, galvanized the nation and propelled the U.S. into a space race that found Neil Armstrong and "Buzz" Aldrin on the moon only seven years later.

"The exploration of space and the unknown is an endless source of fascination to us," said Félix Lajeunesse, co-founder of Felix & Paul Studios and creative director of The Infinite, in a statement.

"We are thrilled to bring The Infinite to Houston — the global epicenter of human space exploration — to share this massive, fully immersive exhibition, and we look forward to virtually transporting thousands of people off the Earth to enjoy the joy and wonder of space with audiences in the U.S. This unprecedented project is made possible thanks to our partners at NASA, the ISS National Lab, international space agencies and the incredible power of virtual reality."

------

This article originally ran on CultureMap.

Ad Placement 300x100
Ad Placement 300x600

CultureMap Emails are Awesome

Texas falls to bottom of national list for AI-related job openings

jobs report

For all the hoopla over AI in the American workforce, Texas’ share of AI-related job openings falls short of every state except Pennsylvania and Florida.

A study by Unit4, a provider of cloud-based enterprise resource planning (ERP) software for businesses, puts Texas at No. 49 among the states with the highest share of AI-focused jobs. Just 9.39 percent of Texas job postings examined by Unit4 mentioned AI.

Behind Texas are No. 49 Pennsylvania (9.24 percent of jobs related to AI) and No. 50 Florida (9.04 percent). One spot ahead of Texas, at No. 47, is California (9.56 percent).

Unit4 notes that Texas’ and Florida’s low rankings show “AI hiring concentration isn’t necessarily tied to population size or GDP.”

“For years, California, Texas, and New York dominated tech hiring, but that’s changing fast. High living costs, remote work culture, and the democratization of AI tools mean smaller states can now compete,” Unit4 spokesperson Mark Baars said in a release.

The No. 1 state is Wyoming, where 20.38 percent of job openings were related to AI. The Cowboy State was followed by Vermont at No. 2 (20.34 percent) and Rhode Island at No. 3 (19.74 percent).

“A company in Wyoming can hire an AI engineer from anywhere, and startups in Vermont can build powerful AI systems without being based in Silicon Valley,” Baars added.

The study analyzed LinkedIn job postings across all 50 states to determine which ones were leading in AI employment. Unit4 came up with percentages by dividing the total number of job postings in a state by the total number of AI-related job postings.

Experts suggest that while states like Texas, California and Florida “have a vast number of total job postings, the sheer volume of non-AI jobs dilutes their AI concentration ratio,” according to Unit4. “Moreover, many major tech firms headquartered in California are outsourcing AI roles to smaller, more affordable markets, creating a redistribution of AI employment opportunities.”

Houston energy trailblazer Fervo closes $462 million Series E

Fresh Funds

Houston-based geothermal energy company Fervo Energy has closed an oversubscribed $462 million series E funding round, led by new investor B Capital.

“Fervo is setting the pace for the next era of clean, affordable, and reliable power in the U.S.,” Jeff Johnson, general partner at B Capital, said in a news release.

“With surging demand from AI and electrification, the grid urgently needs scalable, always-on solutions, and we believe enhanced geothermal energy is uniquely positioned to deliver. We’re proud to support a team with the technical leadership, commercial traction, and leading execution capabilities to bring the world’s largest next-generation geothermal project online and make 24/7 carbon-free power a reality.”

The financing reflects “strong market confidence in Fervo’s opportunity to make geothermal energy a cornerstone of the 24/7 carbon-free power future,” according to the company. The round also included participation from Google, a longtime Fervo Partner, and other new and returning investors like Devon Energy, Mitsui & Co., Ltd., Mitsubishi Heavy Industries and Centaurus Capital. Centaurus Capital also recently committed $75 million in preferred equity to support the construction of Cape Station Phase I, Fervo noted in the release.

The latest funding will support the continued buildout of Fervo’s Utah-based Cape Station development, which is slated to start delivering 100 MW of clean power to the grid beginning in 2026. Cape Station is expected to be the world's largest next-generation geothermal development, according to Fervo. The development of several other projects will also be included in the new round of funding.

“This funding sharpens our path from breakthrough technology to large-scale deployment at Cape Station and beyond,” Tim Latimer, CEO and co-founder of Fervo, added in the news release. “We’re building the clean, firm power fleet the next decade requires, and we’re doing it now.”

Fervo recently won Scaleup of the Year at the 2025 Houston Innovation Awards, and previously raised $205.6 million in capital to help finance the Cape Station earlier this year. The company fully contracted the project's capacity with the addition of a major power purchase agreement from Shell this spring. Fervo’s valuation has been estimated at $1.4 billion and includes investments and support from Bill Gates.

“This new investment makes one thing clear: the time for geothermal is now,” Latimer added in a LinkedIn post. “The world desperately needs new power sources, and with geothermal, that power is clean and reliable. We are ready to meet the moment, and thrilled to have so many great partners on board.”

---

This article originally appeared on EnergyCapitalHTX.com.

Baylor center receives $10M NIH grant to continue rare disease research

NIH funding

Baylor College of Medicine’s Center for Precision Medicine Models received a $10 million, five-year grant from the National Institutes of Health last month that will allow it to continue its work studying rare genetic diseases.

The Center for Precision Medicine Models creates customized cell, fly and mouse models that mimic specific genetic variations found in patients, helping scientists to better understand how genetic changes cause disease and explore potential treatments.

The center was originally funded by an NIH grant, and its models have contributed to the discovery of several new rare disease genes and new symptoms caused by known disease genes. It hosts an online portal that allows physicians, families and advocacy groups to nominate genetic variants or rare diseases that need further investigation or new treatments.

Since its founding in 2020, it has received 156 disease/variant nominations, accepted 63 for modeling and produced more than 200 precision models, according to Baylor.

The center plans to use the latest round of funding to bring together more experts in rare disease research, animal modeling and bioinformatics, and to expand its focus and model more complex diseases.

Dr. Jason Heaney, associate professor in the Department of Molecular and Human Genetics at BCM, serves as the lead principal investigator of the center.

“The Department of Molecular and Human Genetics is uniquely equipped to bring together the diverse expertise needed to connect clinical human genetics, animal research and advanced bioinformatics tools,” Heaney added in the release. “This integration allows us to drive personalized medicine forward using precision animal models and to turn those discoveries into better care for patients.”